355 related articles for article (PubMed ID: 10594030)
21. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
22. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
Wang D; Russell JL; Johnson DG
Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
[TBL] [Abstract][Full Text] [Related]
23. Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.
Minges JT; Grossman G; Zhang P; Kafri T; Wilson EM
J Biol Chem; 2015 Oct; 290(41):25174-87. PubMed ID: 26330556
[TBL] [Abstract][Full Text] [Related]
24. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
25. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
[TBL] [Abstract][Full Text] [Related]
26. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques.
Bennett MR; Macdonald K; Chan SW; Boyle JJ; Weissberg PL
Circ Res; 1998 Apr; 82(6):704-12. PubMed ID: 9546379
[TBL] [Abstract][Full Text] [Related]
27. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
28. ARF differentially modulates apoptosis induced by E2F1 and Myc.
Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
[TBL] [Abstract][Full Text] [Related]
29. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line.
Saito M; Helin K; Valentine MB; Griffith BB; Willman CL; Harlow E; Look AT
Genomics; 1995 Jan; 25(1):130-8. PubMed ID: 7774910
[TBL] [Abstract][Full Text] [Related]
30. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
Good L; Dimri GP; Campisi J; Chen KY
J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
[TBL] [Abstract][Full Text] [Related]
31. E2F and Ras synergize in transcriptionally activating p14ARF expression.
Berkovich E; Lamed Y; Ginsberg D
Cell Cycle; 2003; 2(2):127-33. PubMed ID: 12695664
[TBL] [Abstract][Full Text] [Related]
32. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
33. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
34. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.
Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T
Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967
[TBL] [Abstract][Full Text] [Related]
35. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
Jones SJ; Dicker AJ; Dahler AL; Saunders NA
J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
[TBL] [Abstract][Full Text] [Related]
36. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
[TBL] [Abstract][Full Text] [Related]
37. Selective repression of growth-regulating cdk2, cyclin E and E2F1 genes in human cell senescence.
Kanazawa S; Fujiwara Y; Mizuno K
Kobe J Med Sci; 1994 Dec; 40(5-6):165-74. PubMed ID: 7542356
[TBL] [Abstract][Full Text] [Related]
38. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
39. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Komori H; Ohtani K
Biochem Biophys Res Commun; 2014 Jul; 450(1):240-6. PubMed ID: 24893334
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor proteins as regulators of cell differentiation.
Li ZR; Hromchak R; Mudipalli A; Bloch A
Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
